DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Expected to Announce Earnings of $0.79 Per Share

Analysts forecast that DENTSPLY SIRONA Inc. (NASDAQ:XRAY) will announce earnings per share (EPS) of $0.79 for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for DENTSPLY SIRONA’s earnings, with estimates ranging from $0.73 to $0.81. DENTSPLY SIRONA posted earnings of $0.87 per share during the same quarter last year, which suggests a negative year over year growth rate of 9.2%. The firm is scheduled to issue its next quarterly earnings results on Monday, March 7th.

According to Zacks, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.89 per share for the current financial year, with EPS estimates ranging from $2.84 to $2.92. For the next financial year, analysts forecast that the firm will post earnings of $3.18 per share, with EPS estimates ranging from $2.96 to $3.36. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that cover DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 4th. The medical instruments supplier reported $0.68 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.03. DENTSPLY SIRONA had a net margin of 9.85% and a return on equity of 13.05%. The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the prior year, the company earned $0.67 earnings per share. The firm’s revenue was up 19.4% compared to the same quarter last year.

XRAY has been the subject of a number of research analyst reports. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $68.00 price target for the company in a research report on Thursday, July 29th. TheStreet raised shares of DENTSPLY SIRONA from a “c+” rating to a “b” rating in a research report on Thursday, August 5th. HC Wainwright reduced their price target on shares of DENTSPLY SIRONA from $72.00 to $66.00 and set a “neutral” rating for the company in a research report on Monday, August 9th. Finally, Barrington Research increased their price target on shares of DENTSPLY SIRONA from $77.00 to $79.00 and gave the stock an “outperform” rating in a research report on Friday, August 6th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $67.57.

In other news, SVP Lisa Yankie sold 1,903 shares of DENTSPLY SIRONA stock in a transaction that occurred on Friday, November 19th. The shares were sold at an average price of $52.63, for a total value of $100,154.89. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Walter Petersohn sold 86,431 shares of DENTSPLY SIRONA stock in a transaction on Wednesday, November 17th. The stock was sold at an average price of $54.18, for a total transaction of $4,682,831.58. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by company insiders.

A number of large investors have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD raised its stake in shares of DENTSPLY SIRONA by 16.1% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 18,345,432 shares of the medical instruments supplier’s stock worth $1,160,532,000 after purchasing an additional 2,546,458 shares in the last quarter. BlackRock Inc. raised its stake in shares of DENTSPLY SIRONA by 7.0% during the 3rd quarter. BlackRock Inc. now owns 16,991,458 shares of the medical instruments supplier’s stock worth $986,354,000 after purchasing an additional 1,109,283 shares in the last quarter. Artisan Partners Limited Partnership raised its stake in DENTSPLY SIRONA by 0.4% in the 3rd quarter. Artisan Partners Limited Partnership now owns 11,383,822 shares of the medical instruments supplier’s stock valued at $660,831,000 after acquiring an additional 46,064 shares during the period. State Street Corp raised its stake in DENTSPLY SIRONA by 1.3% in the 2nd quarter. State Street Corp now owns 9,667,282 shares of the medical instruments supplier’s stock valued at $612,593,000 after acquiring an additional 126,604 shares during the period. Finally, Geode Capital Management LLC raised its stake in DENTSPLY SIRONA by 2.8% in the 3rd quarter. Geode Capital Management LLC now owns 4,061,180 shares of the medical instruments supplier’s stock valued at $235,146,000 after acquiring an additional 109,108 shares during the period. 93.46% of the stock is owned by hedge funds and other institutional investors.

Shares of NASDAQ XRAY traded down $0.75 during mid-day trading on Thursday, reaching $51.26. The company had a trading volume of 1,163,448 shares, compared to its average volume of 1,437,835. The stock has a fifty day moving average of $57.08 and a two-hundred day moving average of $61.36. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.13 and a current ratio of 1.60. The company has a market capitalization of $11.21 billion, a price-to-earnings ratio of 26.98, a PEG ratio of 0.85 and a beta of 0.88. DENTSPLY SIRONA has a 12-month low of $50.54 and a 12-month high of $69.54.

About DENTSPLY SIRONA

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.

Recommended Story: What is a CD ladder?

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.